Literature DB >> 20733091

Receptor tyrosine kinase inhibition, hypertension, and proteinuria: is endothelin the smoking gun?

Neeraj Dhaun, David J Webb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20733091     DOI: 10.1161/HYPERTENSIONAHA.110.155762

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

Review 1.  Hypertension in cancer patients.

Authors:  Elie Mouhayar; Abdulla Salahudeen
Journal:  Tex Heart Inst J       Date:  2011

2.  Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor Antagonism.

Authors:  Joevin Sourdon; Franck Lager; Thomas Viel; Daniel Balvay; Rebecca Moorhouse; Evangeline Bennana; Gilles Renault; Pierre-Louis Tharaux; Neeraj Dhaun; Bertrand Tavitian
Journal:  Theranostics       Date:  2017-07-08       Impact factor: 11.556

Review 3.  New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging.

Authors:  Farah Cadour; Franck Thuny; Joevin Sourdon
Journal:  Front Cardiovasc Med       Date:  2022-02-07

Review 4.  Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension.

Authors:  Peter Kruzliak; Gabriela Kovacova; Olga Pechanova
Journal:  Angiogenesis       Date:  2012-12-01       Impact factor: 9.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.